Workflow
Engineered natural killer (NK) cell therapies
icon
Search documents
Nkarta to Participate in Evercore Healthcare Conference
Globenewswire· 2025-12-02 12:09
Core Insights - Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing engineered natural killer (NK) cell therapies for autoimmune diseases [1][3] - The company will participate in the Evercore 8th Annual Healthcare Conference on December 4, 2025, featuring a fireside chat at 10:50 a.m. ET [2] - Nkarta aims to create allogeneic, off-the-shelf NK cell therapies by utilizing its cell expansion and cryopreservation platform combined with proprietary cell engineering technologies [3] Company Overview - Nkarta is advancing a pipeline of NK cell therapies designed for deep therapeutic activity and broad outpatient access [3] - The company emphasizes the importance of its proprietary technologies in enhancing the effectiveness of its therapies [3] - For further information, Nkarta maintains a dedicated section on its website for investors [2][3]
Nkarta to Participate in November Investor Conferences
Globenewswire· 2025-10-30 17:14
Core Insights - Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing engineered natural killer (NK) cell therapies [1][2] - The company will participate in two upcoming investor conferences in November 2025, including the Stifel 2025 Healthcare Conference and TD Cowen's Immunology & Inflammation Summit [1] Company Overview - Nkarta specializes in allogeneic, off-the-shelf NK cell therapies aimed at treating autoimmune diseases [2] - The company utilizes a combination of cell expansion, cryopreservation platforms, proprietary cell engineering technologies, and CRISPR-based genome engineering to develop its therapies [2] - Nkarta aims to create a pipeline of cell therapies designed for deep therapeutic activity and broad outpatient access [2]
Nkarta to Participate in an April Investor Conference
Newsfilter· 2025-04-01 12:01
Company Overview - Nkarta, Inc. is a clinical-stage biotechnology company focused on developing engineered natural killer (NK) cell therapies for autoimmune diseases [2] - The company utilizes a combination of cell expansion, cryopreservation platforms, proprietary cell engineering technologies, and CRISPR-based genome engineering to create its therapies [2] Upcoming Events - Nkarta will participate in the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025, at 11:00 a.m. ET, featuring a fireside chat [1] - A simultaneous webcast of the event will be available on Nkarta's website, with a replay archived for approximately 90 days [1]